As consultants in restorative dentistry working within an acute NHS trust, our role primarily involves working as part of a multidisciplinary head and neck service alongside our orthodontics and maxillofacial colleagues to provide treatment for patients with head and neck cancer, cleft lip and palate, hypodontia, and dentoalveolar and facial trauma. In March 2020, the provision of these essential services was brought to an abrupt halt; with the exception of urgent head and neck cancer care, due to the COVID-19 pandemic. This virus not only impacted how we lived our lives but how we provided key services in hospital dentistry. This article provides clear guidance on personal protective equipment (PPE), infection prevention and control guidance; the role of amber cleans and the integration of laboratory services into safe working environments. We understand that the standard operating procedures in this article are accurate at the time of publication but may be subject to change due to updated government guidelines. Managing risks and alleviating concern: new protocols for patient and staff safety.

Corona virus disease 2019 (COVID19) is a pandemic disease which started in December 2019 in Wuhan, China. Now it has spread all over the world with over 7 crore cases and still counting. The typical symptoms of COVID19 can range from mild to severe respiratory illness. Although the respiratory system complications COVID19 have been the most frequent and life threatening, there are increasing reports of central and peripheral nervous system (PNS) involvement. Various studies done in many countries showed that many COVID19 patients presented with neurological manifestations. There are many review studies available throughout the world describing them. There are not many studies in India, especially in southern states done in COVID19 patients. Hence this observational study is done in Thanjavur medical college hospital , a tertiary care center in Tamilnadu, India, to study the various neurological manifestations found in COVID19 patients.